antibody

PLBD1 (Phospholipase B-like 1, LAMA-like Protein 1, Lamina Ancestor Homolog 1, Phospholipase B Domain-containing Protein 1, FLJ22662)

MBS646897

0.05 mg

580 USD

polyclonal

mouse

nonconjugated

western blot, other

Antibody

PLBD1 (Phospholipase B-like 1, LAMA-like Protein 1, Lamina Ancestor Homolog 1, Phospholipase B Domain-containing Protein 1, FLJ22662)

[PLBD1]

[Anti -PLBD1 (Phospholipase B-like 1, LAMA-like Protein 1, Lamina Ancestor Homolog 1, Phospholipase B Domain-containing Protein 1, FLJ22662)]

[PLBD1 protein; Phospholipase B-like 1; phospholipase B-like 1; PLB homolog 1; LAMA-like protein 1; lamina ancestor homolog 1; putative phospholipase B-like 1; phospholipase B domain-containing protein 1; phospholipase B domain containing 1; LAMA-like protein 1; Lamina ancestor homolog 1; Phospholipase B domain-containing protein 1]

[PLBD1; PLBD1]

PLBL1_HUMAN

Polyclonal

IgG

Mouse

MMADSGKRWADIFSKYNSGTYNNQYMVLDLKKVKLNHSL
DKGTLYIVEQIPTYVEYSEQTDVLRKGYWPSYNVPFHEK
IYNWSGYPLLVQKLGLDYSYDLAPRAKIFRRDQGKVTDT
ASMKYIMRYNNYKKDPYSRGDPCNTICCREDLNSPNPSP
GGCYDTKVADIYLASQYTSYAISGPTVQGGLPVFRWDRF
NKTLHQGMAEVYNFDFITMKPILKLDIK

Recognizes human PLBD1

Affinity Purified. Purified by Protein A affinity chromatography.

Supplied as a liquid in PBS, pH 7.4.

0.4mg/ml

May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Western Blot (WB). Other applications not tested.

Optimal dilutions to be determined by the researcher.

Western Blot (WB)

Immunogen: Full length protein corresponding to aa 1-223 of human PLBD1

Antibodies; Abs to Enzymes, Phospholipase

Phospholipase acting on various phospholipids including phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine and lysophospholipids. May have a role in the defense against invading microorganisms and in the generation of lipid mediators of inflammation.

15029600

BC000909

Q6P4A8

Acyl Chain Remodelling Of PC Pathway (645321); Acyl Chain Remodelling Of PE Pathway (645317); Acyl Chain Remodelling Of PI Pathway (645326); Glycerophospholipid Biosynthesis Pathway (645313); Hydrolysis Of LPC Pathway (645322); Metabolism Pathway (477135); Metabolism Of Lipids And Lipoproteins Pathway (160976); Phospholipid Metabolism Pathway (645312)

Function: Phospholipase acting on various phospholipids including phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine and lysophospholipids. May have a role in the defense against invading microorganisms and in the generation of lipid mediators of inflammation. Ref.4. Subunit structure: May exist as a non-covalently associated tetramer of two 22 kDa and two 42 kDa chains. Ref.4. Subcellular location: Cytoplasmic granule. Secreted Ref.4. Tissue specificity: Expressed in neutrophils and monocytes. Ref.4. Post-translational modification: Proteolytic processing leading to a 22 kDa N-terminal and a 42 kDa C-terminal fragment appears necessary for activity, which seems to derive from the 42 kDa chain. Sequence similarities: Belongs to the phospholipase B-like family. Biophysicochemical propertiespH dependence:Optimum pH is 7.4. Ref.4. Sequence caution: The sequence AAH00909.2 differs from that shown. Reason: Erroneous initiation. The sequence BAB15442.1 differs from that shown. Reason: Erroneous initiation.

0.05 mg

580 USD